Samsung Biologics Co.,Ltd.
207940
Classifica tra le azioni
#496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Prezzo delle azioni
$1,028.49
Capitalizzazione di mercato
$47.88B
Variazione (1 giorno)
-3.67%
Variazione (1 anno)
-18.37%
Paese
KR
Scambia Samsung Biologics Co.,Ltd. (207940)
Categoria
Healthcare
Rapporto P/S per Samsung Biologics Co.,Ltd. (207940)
Rapporto P/S al October 2026 TTM: 14.48
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Samsung Biologics Co.,Ltd., il rapporto P/S attuale (TTM) è 14.48. Alla fine del 2024, era pari a 19.31.
Storico del rapporto P/S per Samsung Biologics Co.,Ltd. da 2014 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 14.48 | -15.84% |
| 2025 | 17.20 | -10.95% |
| 2024 | 19.31 | 27.07% |
| 2023 | 15.20 | -20.91% |
| 2022 | 19.22 | -50.09% |
| 2021 | 38.51 | -18.79% |
| 2020 | 47.42 | 14.90% |
| 2019 | 41.27 | -11.58% |
| 2018 | 46.67 | -16.73% |
| 2017 | 56.06 | 83.95% |
| 2016 | 30.47 | -74.24% |
| 2015 | 118.31 | 15.20% |
| 2014 | 102.70 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| 10.72 | -25.93% |
US
|
|
| 41.70 | 188.07% |
US
|
|
| 4.19 | -71.05% |
AU
|
|
| 5.80 | -59.96% |
BE
|
|
| 10.44 | -27.86% |
NL
|
